News from the healthcare data industry
Investment to Underpin Position as Europe’s Leading Real World Data Provider and enabler of Personalized Precision Medicine ZURICH, Nov. 8, 2022 /PRNewswire/ — BC Platforms (BCP), a global leader in healthcare data management and analytics, today...
A Q&A with Josh Gagne, Vice President and Global Head of Epidemiology, Johnson & Johnson Innovative new medicines and medical technologies undergo robust safety assessments before they are made available...
November 07, 2022 02:31 PM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, an AI-driven health technology company and portfolio company of nference, announced today it has acquired NeuTrace, a medical technology company...
Abstract Background The increased adoption of the internet, social media, wearable devices, e-health services, and other technology-driven services in medicine and healthcare has led to the rapid generation of various...
Chief medical information officers act as key liaisons between clinical and IT teams to ensure technology is both beneficial for clinical workflows and implemented appropriately. Below is a list of...
The Business Journal spoke with Myerson about his approach to building the health care data company and its latest innovations. Source: https://www.bizjournals.com/seattle/news/2022/11/04/truveta-ceo-terry-myerson-interview.html
November 04, 2022 09:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health is pleased to announce their attendance and presence at the ISPOR, The Professional Society for Health Economics and Outcomes...
West Reading, Pa.-based Tower Health tapped Eugene Reilly, MD, as its chief medical information officer and vice president. Dr. Reilly is a surgeon and surgical intensivist, according to a Nov....
In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the impact of detecting patients at increased risk of developing cardiovascular...
There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems...